Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/26 21:30 | 10/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | King-Jones Heidy | MA | O | See Rema | 2 | S.dm | -5,114 | 89.21 | 0 | -57 | 3 | D | |||||||||||||||
10/2/26 21:29 | 5/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | 12 | S | -11,375 | 54.17 | 0 | -210 | 702 | D | |||||||||||||||
10/2/26 21:29 | 6/25/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | 10 | S.dm | -9,424 | 72.96 | 0 | -129 | 98 | D | |||||||||||||||
8/10/26 21:31 | 8/7/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | 1 | S.d | -2,404 | 104.53 | 0 | -23 | 9 | M | ||||||||||||||||
7/2/26 21:33 | 5/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Sloan Sheldon | MA | O | Chief Me | 4 | S.d | -7,354 | 71.43 | 0 | -103 | -100 | 0 | D | ||||||||||||||
6/23/26 21:56 | 6/23/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | D | 1 | S.d | -399,659 | 85.31 | 0 | -4,685 | 812 | I | ||||||||||||||||
6/23/26 21:32 | 6/22/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Henderson Michael Thomas | MA | D | 2 | S | -7,952 | 79.52 | 0 | -100 | 89 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |